Result of GM

RNS Number : 6713G

Omega Diagnostics Group PLC

10 June 2013

 



10 June 2013

Omega Diagnostics Group PLC

(the "Company")

Result of General Meeting

Omega Diagnostics Group PLC (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that at a general meeting of its shareholders held today, all resolutions proposed were duly passed.

Accordingly, the Company confirms that it has completed the placing and subscription of 23,529,412 new ordinary shares of 4 pence each in the capital of the Company (the "New Ordinary Shares") with new and existing shareholders at a price of 17 pence per New Ordinary Share.

The New Ordinary Shares are expected to be admitted to trading on AIM ("Admission") tomorrow and the total number of issued ordinary shares following Admission will be 108,745,669.

The details of the Directors' holdings following Admission are set out in the table below.

Director	Number of ordinary shares following Admission	Percentage of ordinary shares in issue following Admission
David Evans	2,870,134	2.64
Andrew Shepherd	2,659,206	2.45
Jag Grewal	29,412	0.03
Kieron Harbinson	323,562	0.30
Michael Gurner	418,730	0.39
William Rhodes	-	-

Contacts:

Omega Diagnostics Group PLC	Tel: [phone]
Andrew Shepherd, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
Jag Grewal, Group Sales and Marketing Director
finnCap Ltd	Tel: [phone]
Geoff Nash/Christopher Raggett (Corporate Finance)
Mia Gardner (Corporate Broking)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul Cornelius	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

ROMNKKDDDBKDAAD